ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,001Medicare Part D Prescriptions Filled, Including Refills

Rank: 239 out of 1006

$476K Total Retail Price of All Prescriptions

Rank: 249 out of 1006

232 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 232 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 6,813 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 279 279 1 8
SIMVASTATIN 274 261 2 1
METOPROLOL TARTRATE 258 247 3 7
LEVOTHYROXINE SODIUM 246 245 4 2
FUROSEMIDE 240 239 5 6
AMLODIPINE BESYLATE 225 225 6 4
LISINOPRIL 214 201 7 3
OMEPRAZOLE 199 199 8 9
DONEPEZIL HCL 192 192 9 17
ESCITALOPRAM OXALATE 153 134 10 27
ATORVASTATIN CALCIUM 139 138 11 5
SYNTHROID 132 132 12 42
MIRTAZAPINE 130 130 13 26
DIOVAN 122 122 14 16
RISPERIDONE 117 117 15 40
HYDROCHLOROTHIAZIDE 102 102 16 11
CARBIDOPA-LEVODOPA 100 100 17 80
CLOPIDOGREL 99 91 18 46
PRAVASTATIN SODIUM 90 90 19 15
METFORMIN HCL 86 72 20 10
SERTRALINE HCL 78 77 21 19
NAMENDA 76 76 22 34
GABAPENTIN 75 63 23 20
PLAVIX 75 70 23 61
LIDODERM 74 74 25 66
CITALOPRAM HBR 71 70 26 24
METOPROLOL SUCCINATE 70 70 27 12
LOSARTAN POTASSIUM 65 65 28 22
NOVOLOG 61 51 29 94
CYMBALTA 59 57 30 41
LANTUS 58 52 31 43
CIPROFLOXACIN HCL 54 54 32 75
PREDNISONE 54 54 32 33
LEVETIRACETAM 53 53 34 72
LEXAPRO 52 47 35 103
TAMSULOSIN HCL 51 51 36 23
CLONIDINE HCL 51 51 36 165
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.